In Australia, Gene Patents Also Subject of High Court Struggle
By Leigh Dayton,
Science
| 04. 19. 2013
The U.S. Supreme Court isn't the only high court considering a precedent-setting case on patenting human genes. Australia's Full Federal Court this week began proceedings in an appeal of an earlier decision that upheld the validity of breast cancer diagnostic tests developed by Myriad Genetics—the same tests that were the subject of
oral argument before the U.S. high court earlier this week.The Australian legal jousting comes as that nation's policymakers pursue a trio of initiatives that could have far-reaching implications for how Australia handles biomedical patents, including those on human genes. On 2 April, a draft report on pharmaceutical patents that calls for limiting the reach of intellectual property (IP) was unveiled. On 5 April, the government released an independent government review of health and medical research that argues for allowing human gene patents. And on 15 April, a new law that updates the country's patent system came into effect, but it mostly sidesteps the gene patenting issue.
Amid this flurry of activity, many eyes are on the court case, which focuses on the validity of patents held by...
Related Articles
By Margaux MacColl, The San Francisco Standard | 09.17.2025
Designer babies are coming soon to an IVF clinic near you.
Nucleus Genomics, founded by Kian Sadeghi in 2020, when he was just 20, got its start analyzing genomes to weigh a person’s risk of everything from cancer to ADHD...
By Johana Bhuiyan, The Guardian | 09.23.2025
In March 2021, a 25-year-old US citizen was traveling through Chicago’s Midway airport when they were stopped by US border patrol agents. Though charged with no crime, the 25-year-old was subjected to a cheek swab to collect their DNA, which...
By Annika Inampudi, Science | 08.01.2025
In June, Sara* received a message asking whether she wanted to continue to participate in a massive, multicenter research project led by scientists at Aarhus University in Denmark. The iPsych study, the message said, had sequenced her genetic data from...
The Center for Genetics and Society is delighted to recommend the current edition of GMWatch Review – Number 589. UK-based GMWatch, a long-standing ally, was founded in 1998 by Jonathan Matthews as an independent organization seeking to counter the enormous corporate political power and propaganda of the GMO industry and its supporters. Matthews and Claire Robinson are its directors and managing editors.
CGS works to ensure that social justice, equity, human rights, and democratic governance are front...